In particular, eight tumor samples reported a BRAF mutation of which 5 was p.Val600Glu, 1 p.Leu597Arg, 1 p.Val600Lys, and 1 p.Val600Asp all sufficiently covered (>200x) with an VAF > 19.0% (Additional File 2). This evidence concerns the gene BRAF and neoplasm.